GoodRx/$GDRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GoodRx
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Ticker
$GDRX
Sector
Primary listing
Employees
738
Headquarters
Website
GoodRx Metrics
BasicAdvanced
$1.6B
50.34
$0.09
1.24
-
Price and volume
Market cap
$1.6B
Beta
1.24
52-week high
$8.80
52-week low
$3.31
Average daily volume
4.1M
Financial strength
Current ratio
4.206
Quick ratio
3.992
Long term debt to equity
83.622
Total debt to equity
85.15
Interest coverage (TTM)
2.52%
Profitability
EBITDA (TTM)
134.614
Gross margin (TTM)
93.68%
Net profit margin (TTM)
4.33%
Operating margin (TTM)
14.19%
Effective tax rate (TTM)
37.96%
Revenue per employee (TTM)
$1,080,000
Management effectiveness
Return on assets (TTM)
5.08%
Return on equity (TTM)
5.27%
Valuation
Price to earnings (TTM)
50.341
Price to revenue (TTM)
2.114
Price to book
2.44
Price to tangible book (TTM)
89.7
Price to free cash flow (TTM)
14.341
Free cash flow yield (TTM)
6.97%
Free cash flow per share (TTM)
0.313
Growth
Revenue change (TTM)
3.20%
Earnings per share change (TTM)
-160.38%
3-year revenue growth (CAGR)
-0.15%
3-year earnings per share growth (CAGR)
-7.87%
What the Analysts think about GoodRx
Analyst ratings (Buy, Hold, Sell) for GoodRx stock.
GoodRx Financial Performance
Revenues and expenses
GoodRx Earnings Performance
Company profitability
GoodRx News
AllArticlesVideos
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
Fast Company·4 days ago
Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms
Proactive Investors·4 days ago
GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.
Barrons·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GoodRx stock?
GoodRx (GDRX) has a market cap of $1.6B as of August 22, 2025.
What is the P/E ratio for GoodRx stock?
The price to earnings (P/E) ratio for GoodRx (GDRX) stock is 50.34 as of August 22, 2025.
Does GoodRx stock pay dividends?
No, GoodRx (GDRX) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next GoodRx dividend payment date?
GoodRx (GDRX) stock does not pay dividends to its shareholders.
What is the beta indicator for GoodRx?
GoodRx (GDRX) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.